EDGAR Filing Documents for 0001171843-17-002920

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001171843-17-002920

Filing Date

2017-05-10

Accepted

2017-05-10 16:03:53

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	formfour.html	4
1	OWNERSHIP DOCUMENT	formfour.xml	4	3682
	Complete submission text file	0001171843-17-002920.txt		5030

Mailing Address C/O AMBRX, INC. 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037

Business Address

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 17830186

Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850

Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400

Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations